Our global partner, High Grade Pharmaceutical Co., Ltd., has applied for a patent "Drug having Steroids and Fatty Compound" in Taiwan, China und USA at the beginning of the year 2017. The first product of the patent, based on DMS technology and Fluticasone Propionate (INN), a pharmaceutical drug similar to hydrocortisone, was developed with KOKO and launched in Taiwan recently. Among others it is recommended for acute, inflamed cases of neurodermatitis. Advantage: After fast remission of the skin reactions the treatment can be continued subsequently by cosmetic prevention, e.g. with DMS base cream High Classic Plus. For the first time pharmaceutical treatment is combined with sustained corneotherapy by means of lamellar creams.
Lamellar Fluticasone cream